News

25 Years of the Human Genome Project: Unlocking Life’s Code and Imagining the Next Frontier

Twenty-five years ago, an extraordinary milestone was reached in science and medicine: the first full draft of the human genome was completed. The announcement marked the culmination of a decade-long international effort involving over a thousand scientists across six countries, decoding nearly all three billion letters of our DNA—the master code of life.

Back then, the promises were as bold as they were ambitious: a revolution in diagnosing, preventing, and curing diseases like Alzheimer’s, cancer, and diabetes by targeting their genetic roots. While some hopes were premature, the reality has been a story of steady, remarkable progress—and an even more exhilarating future.

A sweeping change is underway in the diagnosis and treatment of traumatic brain injury (TBI), as experts worldwide introduce the CBI-M framework—a multidimensional system designed to provide a far more detailed and individualized understanding of each patient’s condition.

In a remarkable leap forward for neuro-oncology, scientists in the UK have unveiled a pioneering diagnostic tool that dramatically cuts the waiting time for brain tumour classification — from the current six to eight weeks down to just two hours. This new test, called ROBIN (Rapid Nanopore Brain Intraoperative Classification), promises to transform both surgical decision-making and patient care.

In a landmark achievement for precision medicine, researchers have successfully used personalized gene editing to treat an infant suffering from carbamoyl phosphate synthetase 1 (CPS1) deficiency, a rare and life-threatening genetic disorder.

A recent study published in JAMA Network Open has revealed that preterm infants born to mothers affected by preeclampsia show early signs of brain injury, leading to impaired neurodevelopment by age two.

{noindex} Amsterdam, April 29, 2025 — A new study published in The Lancet Regional Health – Europe reveals that researchers at Amsterdam UMC have developed a fast, affordable diagnostic test to detect bacterial meningitis with high accuracy using C-reactive protein (CRP) levels in cerebrospinal fluid (CSF).

A groundbreaking study offers fresh insight into the biological underpinnings of autism spectrum disorder (ASD), using a rare neuromuscular disease as a model to illuminate critical pathways in brain development.

Emerging research suggests that cannabidiol (CBD) extract may offer meaningful benefits for children and adolescents with autism spectrum disorder (ASD), according to a meta-analysis presented at the European Psychiatric Association (EPA) Congress 2025.